Toto, L.; D’Aloisio, R.; Quarta, A.; Libertini, D.; D’Onofrio, G.; De Nicola, C.; Romano, A.; Mastropasqua, R.
Intravitreal Dexamethasone Implant (IDI) Alone and Combined with Navigated 577 nm Subthreshold Micropulse Laser (SML) for Diabetic Macular Oedema. J. Clin. Med. 2022, 11, 5200.
https://doi.org/10.3390/jcm11175200
AMA Style
Toto L, D’Aloisio R, Quarta A, Libertini D, D’Onofrio G, De Nicola C, Romano A, Mastropasqua R.
Intravitreal Dexamethasone Implant (IDI) Alone and Combined with Navigated 577 nm Subthreshold Micropulse Laser (SML) for Diabetic Macular Oedema. Journal of Clinical Medicine. 2022; 11(17):5200.
https://doi.org/10.3390/jcm11175200
Chicago/Turabian Style
Toto, Lisa, Rossella D’Aloisio, Alberto Quarta, Daniele Libertini, Giada D’Onofrio, Chiara De Nicola, Anna Romano, and Rodolfo Mastropasqua.
2022. "Intravitreal Dexamethasone Implant (IDI) Alone and Combined with Navigated 577 nm Subthreshold Micropulse Laser (SML) for Diabetic Macular Oedema" Journal of Clinical Medicine 11, no. 17: 5200.
https://doi.org/10.3390/jcm11175200
APA Style
Toto, L., D’Aloisio, R., Quarta, A., Libertini, D., D’Onofrio, G., De Nicola, C., Romano, A., & Mastropasqua, R.
(2022). Intravitreal Dexamethasone Implant (IDI) Alone and Combined with Navigated 577 nm Subthreshold Micropulse Laser (SML) for Diabetic Macular Oedema. Journal of Clinical Medicine, 11(17), 5200.
https://doi.org/10.3390/jcm11175200
